Наука и жизнь
Feb. 28th, 2016 09:36 amIn cancer science, many "discoveries" don't hold up
http://www.reuters.com/article/us-science-cancer-idUSBRE82R12P20120328
"But they and others fear the phenomenon is the product of a skewed system of incentives that has academics cutting corners to further their careers."
"The surest ticket to getting a grant or job is getting published in a high-profile journal," said Fang. "This is an unhealthy belief that can lead a scientist to engage in sensationalism and sometimes even dishonest behavior."
The academic reward system discourages efforts to ensure a finding was not a fluke. Nor is there an incentive to verify someone else's discovery. As recently as the late 1990s, most potential cancer-drug targets were backed by 100 to 200 publications. Now each may have fewer than half a dozen.
"If you can write it up and get it published you're not even thinking of reproducibility," said Ken Kaitin, director of the Tufts Center for the Study of Drug Development. "You make an observation and move on. There is no incentive to find out it was wrong."
Ничего нового, но странно, что об этом говорят. Ведь на этих исследованиях и публикациях держится все - деньги, должности, образование и т.д.
Апд. Я вспомнила почему я вообще задумывалась об этих статьях. Меня ж израильский тролль троллил на эту тему, мол, если у вас нет пары научных статей, то с вами нет смысла разговаривать. Точно, с трудом, но вспомнила... Как быстро всё интернетовское забывается.
http://www.reuters.com/article/us-science-cancer-idUSBRE82R12P20120328
"But they and others fear the phenomenon is the product of a skewed system of incentives that has academics cutting corners to further their careers."
"The surest ticket to getting a grant or job is getting published in a high-profile journal," said Fang. "This is an unhealthy belief that can lead a scientist to engage in sensationalism and sometimes even dishonest behavior."
The academic reward system discourages efforts to ensure a finding was not a fluke. Nor is there an incentive to verify someone else's discovery. As recently as the late 1990s, most potential cancer-drug targets were backed by 100 to 200 publications. Now each may have fewer than half a dozen.
"If you can write it up and get it published you're not even thinking of reproducibility," said Ken Kaitin, director of the Tufts Center for the Study of Drug Development. "You make an observation and move on. There is no incentive to find out it was wrong."
Ничего нового, но странно, что об этом говорят. Ведь на этих исследованиях и публикациях держится все - деньги, должности, образование и т.д.
Апд. Я вспомнила почему я вообще задумывалась об этих статьях. Меня ж израильский тролль троллил на эту тему, мол, если у вас нет пары научных статей, то с вами нет смысла разговаривать. Точно, с трудом, но вспомнила... Как быстро всё интернетовское забывается.
no subject
Date: 2016-02-28 07:08 pm (UTC)no subject
Date: 2016-02-29 02:41 pm (UTC)